About Us
Science Programs
Pipeline
Clinical Trials
Careers
cONTACT
Resources
Corporate Presentation
Posters, PRESENTATIONS & Publications
MEDIA
Events
News & press releases
Investors
Overview
Stock Information
Analyst Coverage
Stock Quote & Chart
Historical Price Lookup
Investment Calculator
Financials & SEC FILINGS
Sec Filings
Quarterly Results
cORPORATE GOVERNANCE
Management Team
Board of Directors
Committee Composition
Governance Documents
News & Press Releases
Get up to speed with Rain!
Filter by year...
2022
2021
2020
2019
2018
Reset Filter
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
December
13
,
2023
Rain Oncology Enters into Agreement to be Acquired by Pathos AI for $1.16 in Cash per Share Plus Contingent Value Rights
Download PDf
November
9
,
2023
Rain Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update
Download PDf
October
16
,
2023
Rain Oncology Confirms Receipt of Unsolicited Proposal from Concentra Biosciences
Download PDf
August
10
,
2023
Rain Oncology Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Download PDf
July
26
,
2023
Rain Oncology to Report Second Quarter 2023 Financial Results and Provide a Corporate Update on August 10, 2023
Download PDf
May
30
,
2023
Rain Oncology Provides Company Update and Outlines Strategic Priorities of Milademetan Clinical Programs
Download PDf
May
22
,
2023
Rain Oncology Announces Topline Results from Phase 3 MANTRA Trial of Milademetan for the Treatment of Dedifferentiated Liposarcoma
Download PDf
May
11
,
2023
Rain Oncology Reports First Quarter 2023 Financial Results and Highlights Recent Progress
Download PDf
April
24
,
2023
Rain Oncology to Report First Quarter 2023 Financial Results and Highlights Recent Progress on May 11, 2023
Download PDf
April
5
,
2023
Rain Oncology Announces Collaborator Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2023
Download PDf
#
Next
